mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.8 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |